Publications

5674 Results

Interferon regulatory factor-1 (IRF-1): A candidate tumor suppressor gene on chromosome 5q31-1 deleted in leukemia and myelodysplasia (MDS) with del (5q) or translocation of 5q31.

Authors
CL Willman;C Sever;M Pallavicini;H Harada;N Tanaka;M Slovak;A List;H Yamamoto;K Harada;T Taniguchi
Journal / Conference
Blood 80:74a(#286)
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

The human cell cycle gene CDC25C maps to chromosome 5q31.1 within 100 KB of interferon regulatory factor-1 (IRF-1) in the critical region deleted in myelodysplasia (MDS) and leukemia with 5q abnormalities.

Authors
C Sever;CL Willman;H Harada;T Taniguchi;W Kuo;M Pallavicini;M Slovak;T Meeker
Journal / Conference
Blood 80(10)-Suppl.1:195a(#769)
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Evaluation of the proliferative fraction of cytogenetically normal and aberrant hemopoietic subpopulations in acute myeloid leukemia (AML and myelodysplasia (MDS).

Authors
TI George;B Mehrotra;CL Willman;PI Greenberg;MG Pallavicini
Journal / Conference
Blood 80(10)-Suppl.1:30a
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Variable frequency of cytogenetically aberrant cells in the stem cell compartment and hemopoietic lineages in acute myeloid leukemia (AML) and myelodysplasia (MDS).

Authors
B Mehrotra;C Mar;WL Kuo;CL Willman
Journal / Conference
Blood 80(10)-Suppl.1:30a
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

Precise localization of the long arm breakpoint of the inv(16) of ANNL M4Eo and progress towards cloning this breakpoint.

Authors
D Callen;B Kuss;CL Willman;H Eyre;J Nancarrow;N Lapsys;RI Richards;GR Sutherland
Journal / Conference
Am J Human Genetics 51(4):57A
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007

The use of MRS to monitor drug biodistribution, targeting and metabolism

Authors
W Wolf;CA Presant;V Waluch
Journal / Conference
Presented at the 17th LH Gray Conference on Tumor Biology-April 12-16
Year
1992
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006

Phase III study comparing sequential chemotherapy (CT) and radiotherapy (RT) to RT for resected and negative margins squamous cell carcinoma of the head and neck: Intergroup study #0034.

Authors
M Al-Sarraf;CB Scott;K Ahmad;JG Schwade;D Schuller;GE Laramore;J Jacobs
Journal / Conference
Proc of the American Society of Clinical Oncology 11:242(#778)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Unappreciated impact of potentially "curative" surgery (pcs) in multi-modality head and neck (h+n) trials upon sample size requirements.

Authors
TF Pajak;JR Jacobs
Journal / Conference
International Conference on Head and Neck cancer-San Francisco :121(#283)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Chemotherapy as predector of compliance.

Authors
JR Jacobs;RA Casiano;DE Schulller;TF Pajak;GE Laramore;M Al-Sarraf
Journal / Conference
International Conference on Head and Neck Cancer 62(#49)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Is a surgical resection leaving positive margins of benefit to the patient with locally-advanced squamous cell carcinoma of hte head and neck?

Authors
GE Laramore;CB Scott;DE Schuller;RE Haselow;TJ Ervin;R Wheeler;M Al-Sarraf;RA Gahbauer;JR Jacobs;JG Schwade;BH Campbell
Journal / Conference
Proc of the 34th Annual ASTRO Meeting 24:173(#83)
Year
1992
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)